{"data":[{"accessionNo":"0000070858-26-000531","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"G6014T100","securityClass":"Ordinary Shares","eventDate":"2026-09-30","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":26889300,"percentOfClass":3.4,"filedAt":"2026-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000413","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"589492107","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":5000000,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000413","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"589492107","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":5000000,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000413","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"589492107","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4732750,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000265","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"589492107","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":66844275,"percentOfClass":8.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000265","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"589492107","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":66844275,"percentOfClass":8.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000265","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"589492107","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":62644610,"percentOfClass":7.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000070858-26-000293","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":"G6014T100","securityClass":"Ordinary shares","eventDate":"2026-03-31","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":40976460,"percentOfClass":5.1,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001274173-26-000065","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001719714","issuerName":"MEREO BIOPHARMA GROUP PLC","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2025-12-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"Northpond Ventures, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"Northpond Ventures GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"Northpond Ventures II, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"Northpond Ventures II GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"NPV Listed, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"Northpond Ventures, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001867472-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, par value GBP 0.003 per share","eventDate":"2025-12-31","reportingPerson":"Michael P. Rubin","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"FHMLSP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"FHMLSP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"FHMLS X, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"FHMLS X, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"FHMLS XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"James N. Topper","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001231919-26-000157","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares","eventDate":"2025-12-31","reportingPerson":"Patrick J. Heron","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2026-01-02","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":74500000,"percentOfClass":9.4,"filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2026-01-02","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":74500000,"percentOfClass":9.4,"filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0000935836-26-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2026-01-02","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":69802840,"percentOfClass":8.8,"filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001404574-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares, each representing five ordinary shares, nominal value of 0.003 GBP per share","eventDate":"2025-12-29","reportingPerson":"683 Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":65083815,"percentOfClass":8.18,"filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001404574-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares, each representing five ordinary shares, nominal value of 0.003 GBP per share","eventDate":"2025-12-29","reportingPerson":"683 Capital Partners, LP","reportingCik":null,"personType":"PN","sharesOwned":65083815,"percentOfClass":8.18,"filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001404574-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares, each representing five ordinary shares, nominal value of 0.003 GBP per share","eventDate":"2025-12-29","reportingPerson":"Ari Zweiman","reportingCik":null,"personType":"IN","sharesOwned":65083815,"percentOfClass":8.18,"filedAt":"2026-01-06","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001274173-25-000290","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001719714","issuerName":"MEREO BIOPHARMA GROUP PLC","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":16290130,"percentOfClass":10.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001274173-25-000290","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001719714","issuerName":"MEREO BIOPHARMA GROUP PLC","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-09-30","reportingPerson":"Janus Henderson Biotech Innovation Master Fund Ltd","reportingCik":null,"personType":"IV","sharesOwned":13759885,"percentOfClass":8.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001172661-25-004855","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share","eventDate":"2025-09-30","reportingPerson":"Mangrove Partners IM, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":38952900,"percentOfClass":4.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"},{"accessionNo":"0001172661-25-004855","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001719714","issuerName":"Mereo BioPharma Group plc","ticker":"MREO","cusip":null,"securityClass":"American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share","eventDate":"2025-09-30","reportingPerson":"Nathaniel August","reportingCik":null,"personType":"HC,IN","sharesOwned":38952900,"percentOfClass":4.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mreo"}],"updatedAt":"2026-11-03T23:38:18.400Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mreo","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}